1nkemia estudia ampliar capital para financiar su expansión exterior
Intel ID : 214388
|
Synopsis
17 JAN 2014
|
|
(content in spanish)
La biotecnológica española 1nKemia ha acordado estudiar una posible ampliación de capital durante el primer semestre de 2014 para financiar la expansión de su negocio. 1nkemia, fundada en 1997 en la Mollet del Vallés (Barcelona), se dedica a la investigación y desarrollo de productos para la industria química, farmacéutica y biotecnológica. La empresa registró en 2012 unos ingresos de EUR 2,27m con un beneficio de EUR 1,03m. |
| Intel ID | 214388 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - 1nKemia
(31 Dec 2017) |
Revenue: EUR 0,18m Net Debt: EUR 18,45m People: 10 |
|
| Date |
|
|
| Country | ![]() |
|
| Region | ||
| Continent | ![]() |
|
| Geography | ![]() |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | ![]() |
Issuer
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
10.01.01 BPO/Outsource Services 10 Business Services / 10.01 Business & Professional Support Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.
